EUVIMEDEUVIMED entdecken
Open Access

Recall and Appraisal of the Risks, Benefits, and Objectives of Interrupting HIV Treatment in an HIV Cure-Related Study

Anastasia Korolkova, Samuel O Ndukwe, Lynda Dee, Steven G Deeks, Michael J Peluso, Rebecca Hoh, Antonio Rodriguez, Jeremy Sugarman, Lidia Rodriguez Garcia, Karine Dubé, John A Sauceda

AIDS and Behavior · 2024

DOI: 10.1007/s10461-024-04485-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS and Behavior, 2024. Verfasst von Anastasia Korolkova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego (UCSD), La Jolla, CA, USA. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections, Mental Recall, Treatment Interruption. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIMH NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsHIV InfectionsMental RecallTreatment InterruptionAdultFemaleHumansMaleMiddle AgedInformed ConsentInterviews as TopicRisk AssessmentSan FranciscoTherapeutic MisconceptionClinical Studies as Topic

Stichwörter der Autor:innen

Consent understandingsHIV cureRisks and benefitsSocial scienceTreatment interruptions

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego (UCSD), La Jolla, CA, USA.
  • AIDS Action Baltimore, Baltimore, MD, USA.
  • Delaney AIDS Research Enterprise (DARE) Community Engagement Coordinator, UCSF, San Francisco, CA, USA.
  • Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco (UCSF), San Francisco, CA, USA.
  • Johns Hopkins Berman Institute of Bioethics, Baltimore, MD, USA.
  • Division of Prevention Sciences, Department of Medicine, UCSF, San Francisco, CA, USA.

Förderung

  • NIAID NIH HHS
  • NIMH NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • National Institute of Mental Health

Zitieren

APA

Korolkova, A., Ndukwe, S. O., Dee, L., Deeks, S. G., Peluso, M. J., Hoh, R., Rodriguez, A., Sugarman, J., Rodriguez Garcia, L., Dubé, K., & Sauceda, J. A. (2024). Recall and Appraisal of the Risks, Benefits, and Objectives of Interrupting HIV Treatment in an HIV Cure-Related Study. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04485-x

Vancouver

Korolkova A, Ndukwe SO, Dee L, Deeks SG, Peluso MJ, Hoh R, et al. Recall and Appraisal of the Risks, Benefits, and Objectives of Interrupting HIV Treatment in an HIV Cure-Related Study. AIDS and Behavior. 2024. doi:10.1007/s10461-024-04485-x

BibTeX
@article{Korolkova2024,
  author = {Korolkova, Anastasia and Ndukwe, Samuel O and Dee, Lynda and Deeks, Steven G and Peluso, Michael J and Hoh, Rebecca and Rodriguez, Antonio and Sugarman, Jeremy and Rodriguez Garcia, Lidia and Dubé, Karine and Sauceda, John A},
  title = {Recall and Appraisal of the Risks, Benefits, and Objectives of Interrupting HIV Treatment in an HIV Cure-Related Study},
  journal = {AIDS and Behavior},
  year = {2024},
  doi = {10.1007/s10461-024-04485-x}
}
Kostenlos starten →